Binance Labs Invests in DeSci Platform BIO Protocol

Binance Labs, the venture capital arm of Binance, has announced its investment in BIO Protocol, a platform designed to help early-stage scientific research startups access decentralized funding opportunities.
The investment sees Binance, powered by the native token BNB (
BNB
), make its first foray into decentralized science, the platform said in an
announcement
on Nov. 8.
According to Binance Labs, BIO Protocol is the equivalent of the “Y Combinator of on-chain science”, a reference to the U.S.-based VC firm and startup accelerator.
Read more:
Tether completes first Middle East crude oil transaction
BIO Protocol advances the DeSci sector by providing a platform for scientists and investors to access collective funding and co-ownership opportunities.
The platform currently operates through a network of seven biotech decentralized autonomous organizations, (also known as BioDAOs) covering areas such as women’s health, mental health, and cryopreservation.
The BIO Protocol team plans to use the funding to expand its BioDAOs further, with seed funding available for new entities. BIO will also offer community and tokenomics support as it seeks to broaden its presence and impact in scientific funding.
Binance Labs has recently increased its footprint in the VC ecosystem, backing multiple projects in various industry fields. This includes the
investment platform’s backing of Lombard
, a Bitcoin (
BTC
) liquid staking platform.
The crypto and blockchain-focused venture capital provider has also invested in Solana (
SOL
) staking protocol Solayer and Telegram mini-app Blum.
Read more:
Binance bets on Thailand as region signals supportive crypto approach